Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Tartrazine for Skin Transparency
NCT06800183Phase 1Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- May 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of tartrazine, sponsored by Johns Hopkins University. Primary endpoint: Optical Transparency as Assessed by Total Transmittance Percentage up to 90 minutes. Planned start May 2026; status: withdrawn.
02
Drugs
tartrazine
Beyond the preview
Go deeper on NCT06800183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06800183.